Cutaneous reactions to transdermal therapeutic systems.

by Admin

Call 1 (888) 460-6556 to speak with a counselor.

Author: news_poster

Posted: Thu Jul 28, 2011 2:00 am

Authors: Bershow A, Warshaw E
Transdermal therapeutic systems (TTSs) are commonly used to treat many diverse medical conditions. There are several advantages to this form of drug delivery; however, adverse cutaneous reactions are common. This review article provides an update on skin reactions due to TTSs containing medications newly available in TTS form, including buprenorphine, diclofenac, lidocaine, oxybutynin, rotigotine, methylphenidate, rivastigmine, teriparatide, and nicardipine.
PMID: 21781635 [PubMed – in process] (Source: Dermatitis)

Read more…

Source: MedWorm Query: Buprenorphine
MedWorm.com provides a medical RSS filtering service. Data from over 6000 medical RSS feeds is collected and output via different categories. This feed contains the latest headlines from the user generated query: Buprenorphine

Previous post:

Next post: